Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Taysha Gene Therapies, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−5 vs. Q1 2023
Shares held
13.7M
−2.99M (−17.9%) vs. Q1 2023
Total value
$9.05M
−$4.23M (−31.9%) vs. Q1 2023
New holders
2
10 more added
Sold out
7
11 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 39 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ2 2023: $9.05M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q1 2023.

Institutions holding TSHA in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc1,589,248$1.05M0.00%+5,810+0.4%Added
Tybourne Capital Management (HK) Ltd1,500,000$991.5K0.11%00.0%Unchanged
Artal Group S.A.1,440,882$952.0K0.03%00.0%Unchanged
Nantahala Capital Management, LLC1,251,139$827.0K0.10%−471,261−27.4%Reduced
Laurion Capital Management LP1,171,832$774.6K0.03%−120,768−9.3%Reduced
FMR LLC1,148,827$759.4K0.00%−1,938,511−62.8%Reduced
Franklin Resources Inc810,840$536.0K0.00%00.0%Unchanged
Sands Capital Ventures, LLC724,873$478.4K0.14%00.0%Unchanged
Alphabet Inc.640,882$423.0K0.02%00.0%Unchanged
Millennium Management LLC614,938$406.5K0.00%+137,893+28.9%Added
Quantum Private Wealth, LLC504,380$333.4K0.15%+145,013+40.4%Added
Carlson Capital L P484,000$319.9K0.03%−20,000−4.0%Reduced
Geode Capital Management, LLC357,853$236.5K0.00%−18,611−4.9%Reduced
BlackRock Inc.321,025$212.2K0.00%−76,460−19.2%Reduced
Renaissance Technologies LLC224,400$148.0K0.00%−25,200−10.1%Reduced
Bridgeway Capital Management, LLC156,300$103.3K0.00%00.0%Unchanged
Morgan Stanley131,308$86.8K0.00%+43,495+49.5%Added
State Street Corp114,920$76.0K0.00%00.0%Unchanged
Squarepoint Ops LLC80,634$53.3K0.00%+80,634New
Northern Trust Corp72,958$48.2K0.00%00.0%Unchanged
Acadian Asset Management LLC70,798$46.0K0.00%−334,503−82.5%Reduced
Dynamic Advisor Solutions LLC45,000$29.7K0.00%+45,000New
Redwood Wealth Management Group, LLC38,050$25.2K0.03%+300+0.8%Added
Bank of America Corp29,431$19.5K0.00%−107,570−78.5%Reduced
Sargent Investment Group, LLC25,634$16.9K0.00%+6,065+31.0%Added
Wells Fargo & Company19,193$12.7K0.00%+15,148+374.5%Added
Gsa Capital Partners LLP18,077$12.0K0.00%−9,261−33.9%Reduced
Commonwealth Equity Services, LLC18,725$12.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc16,140$10.7K0.00%00.0%Unchanged
Kovitz Investment Group Partners, LLC15,000$9.91K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)14,435$9.54K0.00%+7,180+99.0%Added
Engineers Gate Manager LP13,650$9.02K0.00%00.0%Unchanged
Citadel Advisors LLC11,293$7.46K0.00%00.0%Unchanged
Camelot Portfolios, LLC11,000$7.27K0.00%00.0%Unchanged
UBS Group AG7,909$5.23K0.00%+4,359+122.8%Added
Simplex Trading, LLC5,881$3.00K0.00%−4,886−45.4%Reduced
JPMorgan Chase & Co1,782$1.18K0.00%00.0%Unchanged
Allworth Financial LP1,000$6610.00%00.0%Unchanged
Royal Bank of Canada150$00.00%+128+581.8%Added
Susquehanna International Group, LLP0$00.00%−100,044−100.0%Sold out
XTX Topco Ltd0$00.00%−85,167−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−55,359−100.0%Sold out
Bank of Montreal0$00.00%−49,084−100.0%Sold out
Virtu Financial LLC0$00.00%−45,459−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−10,000−100.0%Sold out
Group One Trading, L.P.0$00.00%−3,991−100.0%Sold out